Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.

Trial Profile

Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2013

At a glance

  • Drugs Etoposide; Gemcitabine
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jan 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov, last updated 16 Jan 2009.
    • 16 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top